Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?

To: WTDEC who wrote (23)	3/5/1998 9:34:00 AM
From: Arthur Radley	Read Replies (1) \| Respond to of 626

Morning, The only major firm is Gerard Mattison Klauer(sp) and I hope to have my hands on their report in the next couple of days. If I get it I would be happy to send you a copy. I agree that their financials could be in better shape but with the recent payment from Novartis, they should be in better shape. Also, the Sturza Medical Letter is recommending the stock.

To: WTDEC who wrote (23)	3/5/1998 11:11:00 AM
From: Pseudo Biologist	Read Replies (1) \| Respond to of 626

W, Everen Securities (is this "Wall Street"?) has issued a report, which the company will send you if you ask. As for the cash position, do not overlook the $23 mill from Novartis; the balance sheet by the end of 97 (not released yet) should have close to $28-29 mill in the cash+short term investments box. At least that's how the Sturza report, also sent to you by Titan if you ask, figured it out last December. The Sturza letter has a web page sturzas.com PB